Arcadia Biosciences, Inc.

Good day, and thank you for standing by, and welcome to the Arcadia Biosciences Q4 2022 Financial Results and Business Highlights Conference Call. At this time, I'll participate on a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would not like to hand the conference over to Arcadia Biosciences.

Please go ahead.

Earnings Conference Call. I'm T.J. Schaffer, Chief Financial Officer, and presenting with me today will be Stan Jacob, President and Chief Executive Officer. This call is being webcast and you can refer to the company's press release at ArcadiaBio.com. Before we start, we would like to remind you that Arcadia Biosciences will be making forward-looking statements on this call based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied today. you can review the company's Safe Harbor language in our most recently filed 10-K. With that, I'll now turn the call over to Stan.